Statins not linked to muscle pain
Article written by Bruce Sylvester British researchers report finding no link between statin therapy and muscle pain. The findings appeared on Feb.28, 2021 in the BMJ/British Medical Journal.
Article written by Bruce Sylvester British researchers report finding no link between statin therapy and muscle pain. The findings appeared on Feb.28, 2021 in the BMJ/British Medical Journal.
GW Pharmaceuticals plc , a world leader in discovering, developing and delivering regulatory approved cannabis-based medicines, announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for… read more.
Article written by Gary Finnegan. The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended six medicines for approval at its February 2021 meeting:
Kite, a Gilead Company announced that the FDA has granted accelerated approval to Yescarta (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory follicular lymphoma… read more.
Article written by Gary Finnegan. Regulators around the globe are aligning their approaches to the approval of vaccines and medicines against COVID-19. Closer cooperation is seen as crucial… read more.
The FDA approved Pfizer Inc.’s supplemental New Drug Application (sNDA) for Lorbrena (lorlatinib), expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase (ALK)-positive non-small… read more.
Interview and article by Christine Clark In the first ten years of the UK national HPV vaccination programme more than ten million doses of HPV vaccine were given… read more.
Article written by Gary Finnegan. New COVID-19 vaccines against variants of the virus could be approved much more quickly than the first generation of jabs. The European Medicines… read more.
AstraZeneca Pharma India Limited announced that it has received marketing approval for Tagrisso (Osimertinib) for adjuvant treatment after complete tumour resection in patients with non-small cell lung cancer… read more.
Gilead Sciences, Inc. announced new, long-term data from open-label extensions (OLE) of two Phase III studies (Study 1489 and Study 1490) of Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir… read more.
Article written by Gary Finnegan. People are more willing to reshare calls for social distancing if the message is endorsed by a well-known expert – such as US… read more.
Interview and article by Christine Clark Dr Peter English, a consultant in communicable disease control describes the UK HPV vaccination strategy and the associated issues.